MiR-490 was reported to diminish the metastasis of different HCC cell lines by reducing the transcriptional levels of E2F Transcription Factor 2 (E2F2) and Epithelial Cell Transforming Sequence 2 (ECT2) factors. Here, E2F2 is linked to hepatocellular carcinoma.